* This is the latest step by the companies to help make Praluent more accessible and affordable for appropriate patients
* Beginning in early March 2019, new U.S. National Drug Code (NDC) options will be available at approximately 60% less than the original price
* Out-of-pocket costs for Medicare patients could be lowered to approximately $25 to $150 per month, a potential savings of up to $345*, depending on their insurance plan
PR Newswire
BRIDGEWATER, N.J. and TARRYTOWN, N.Y., Feb. 11, 2019
